Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.08 USD | -2.40% | +1.45% | -10.85% |
10/05 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
08/05 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.85% | 143.46Cr | |
+31.37% | 59TCr | |
-2.60% | 36TCr | |
+20.83% | 33TCr | |
+5.69% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+10.77% | 17TCr | |
+0.10% | 16TCr |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- RBC Cuts Price Target on Pacira BioSciences to $68 From $70, Maintains Outperform Rating